Two Sigma Investments’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Buy
106,393
+29,791
+39% +$521K ﹤0.01% 2558
2025
Q4
$1.3M Sell
76,602
-209,819
-73% -$3.69M ﹤0.01% 2749
2025
Q3
$6.22M Buy
286,421
+71,869
+33% +$1.19M 0.01% 1286
2025
Q2
$3.06M Buy
214,552
+132,197
+161% +$2.09M 0.01% 1547
2025
Q1
$1.07M Sell
82,355
-30,103
-27% -$455K ﹤0.01% 2134
2024
Q4
$1.5M Buy
+112,458
New +$1.14M ﹤0.01% 1916
2024
Q3
Sell
-16,485
Closed -$54.2K 3170
2024
Q2
$54.2K Sell
16,485
-15,305
-48% -$53.6K ﹤0.01% 2880
2024
Q1
$119K Sell
31,790
-20,710
-39% -$90.4K ﹤0.01% 2813
2023
Q4
$230K Sell
52,500
-27,052
-34% -$108K ﹤0.01% 2779
2023
Q3
$332K Buy
+79,552
New +$307K ﹤0.01% 2451
2021
Q4
Sell
-18,070
Closed -$91K 4437
2021
Q3
$91K Buy
+18,070
New +$94K ﹤0.01% 4093
2021
Q2
Sell
-139,989
Closed -$1.02M 4181
2021
Q1
$1.02M Buy
139,989
+13,499
+11% +$115K ﹤0.01% 2289
2020
Q4
$1.03M Buy
+126,490
New +$976K ﹤0.01% 1995

Other funds holding ETON

Two Sigma Investments's ETON Position: Q1 2026 in Review

Two Sigma Investments increased its Eton Pharmaceutcials (ETON) stake by 39% in Q1 2026, buying an estimated $521K and bringing the position to 106,393 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Two Sigma Investments first reported a position in ETON in Q4 2020 and has held it in 13 quarters since. The position peaked at $6.22M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Two Sigma Investments held 106,393 shares of Eton Pharmaceutcials worth $2.63M as of Q1 2026.
  • Two Sigma Investments bought 29,791 Eton Pharmaceutcials shares in Q1 2026, an estimated $521K.
  • Eton Pharmaceutcials made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2558 holding.
  • Two Sigma Investments first reported a position in Eton Pharmaceutcials in Q4 2020 and has held it in 13 quarters since.
  • Two Sigma Investments's Eton Pharmaceutcials position peaked at $6.22M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.